DI

ํ‡ด์› ์‹œ 2์‹œ๊ฐ„ ์ „์— lab f/u(ECG, Gas, CPK, CE, BUN Cr, LFT, electro CRF) ํ•˜๊ณ ์„œ ๊ดœ์ฐฎ์œผ๋ฉด ํ‡ด์›

  1. resuscitation, stabilize airway breathing circulation(ABC) - ํ•„์š” ์‹œ mechanical airway, assisted ventilation - IV crystalloid(10-20ml/kg) 1st tx of hypotension

  2. antidote

  3. hypoglycemia - IV dextrose - Wernicke encephalopathy ๋Š” thiamine ์ค˜์•ผ ํ•˜์ง€๋งŒ, ๋จผ์ € dextrose ๋ฅผ ์ค˜๋ด์•ผ ํ•œ๋‹ค

  4. seizure - IV benzodiazepine โ†’ propofol, barbiturate - levetiracetam ์€ ํšจ๊ณผ ์ž…์ฆ ์•ˆ๋˜์—ˆ๊ณ , phenytoin ์€ ํšจ๊ณผ ์ž…์ฆ๋„ ์•ˆ๋˜์—ˆ๊ณ , ๋…์„ฑ์„ ์•…ํ™”์‹œํ‚ฌ ์ˆ˜๋„ ์žˆ์Œ - isoniazid(๊ฒฐํ•ต์•ฝ) induced seizure ๋Š” pyridoxine ์ค˜์•ผ ํ•จ

  5. agitation - IV benzodiazepine - 2nd drug ๋กœ antipsychotics(haloperidol ๋“ฑ) ์žˆ์ง€๋งŒ, anticholinergic, extrapyramidal effect๋กœ์˜ disadvantage ์žˆ์–ด ์‚ฌ์šฉ ์•ˆ ํ•จ

  6. fever - 39๋„ ๋„˜๋Š” ๊ฒฝ์šฐ aggressive cooling - rhabdomyolysis, organ failure, DIC ๋“ฑ์˜ ํ•ฉ๋ณ‘์ฆ ๊ฐ€๋Šฅํ•ด์„œ - specific pharmaceutical agent = sympathomimetic - BZD, serotonin - cyproheptadine, neuromuscular malig SD - bromocriptine

  7. naloxone - nontoxic, diagnostic, and therapeutic antidote - ์ฃผ๊ณ  ๋‚˜์„œ RR>12ํšŒ ์ด์ƒ์ด๊ฑฐ๋‚˜, ๊นจ๊ฑฐ๋‚˜ ์›€์ง์ด๋ฉด ๋ฐ˜์‘ ์žˆ๋Š” ๊ฒƒ = opioid ์ค‘๋… - 20-60๋ถ„ ์ง€์† ํšจ๊ณผ, iv naloxone ์ฃผ๊ณ  ๋‚˜์„œ 2-3์‹œ๊ฐ„์€ observation ํ•„์š”


Chapter 177. cyclic antidepressant - ๊ฐ•๋ฐ• ์žฅ์• , ADHD, panic disorder, anxiety disorder ์น˜๋ฃŒ์ œ๋กœ ์‚ฌ์šฉ๋จ - TCA, amitriptyline, clomipramine, doxepin, imipramine, trimipramine - serotonin reuptake block, NE reuptake block, anticholinergic side effect, sodium channel block(wide QRS complex)


Chapter 178. atypical and serotonergic antidepressants - second generation antidepressant์œผ๋กœ ์œ„์—์ฒ˜๋Ÿผ ์šฐ์šธ์ฆ, ๊ฐ•๋ฐ•์žฅ์• , panic disorder, ์„ญ์‹์žฅ์•  ์น˜๋ฃŒ์ œ๋กœ ์‚ฌ์šฉ๋จ - neurotransmitter reuptake inhibit, negative feedback loop interupt ๋กœ ์ž‘์šฉ - ์ด ์•ฝ์€ hepatic enzyme ์— ์˜ํ•ด ๋Œ€์‚ฌ๋˜์–ด, ๊ฐ„์— ์˜ํ•ด ๋ถ„ํ•ด๋˜๋Š” ์•ฝ๋ฌผ๊ณผ ์ƒํ˜ธ์ž‘์šฉ ๊ฐ€๋Šฅํ•˜๊ณ , ๊ฐ„ ๊ธฐ๋Šฅ์ด ์•ˆ ์ข‹์œผ๋ฉด ํ˜ˆ์ค‘ drug level ์ฆ๊ฐ€ ๊ฐ€๋Šฅ - ๋ณ‘์› serum, urine drug screen ์—์„œ ๋ฐฐ์ถœ ์•ˆ ๋จ

*Atypical antidepressant

  1. Bupropion (3/24 ์‘๊ธ‰์‹ค ๋‚ด์›, ์„œ๋ฐฉ์ • ๋ณต์šฉ์œผ๋กœ 24์‹œ๊ฐ„ ์ด์ƒ ์˜ต์ € ํ›„ ํ‡ด์›, ๊ฒฝ๋ จ)
  2. NE, dopamine reuptake ๋ฅผ ๊ฐ์†Œ์‹œํ‚ด, with minimal serotonergic activity
  3. regualr release tablet ์€ 2์‹œ๊ฐ„ ๋‚ด, sustained release tablet ์€ 3์‹œ๊ฐ„ ๋‚ด ์„ญ์ทจ ํ›„ ํก์ˆ˜๋จ
  4. ๋ถ€์ž‘์šฉ = tremor(m/c side effect than other antidepressants), dizziness, agitation, nausea, headache, dry mouth, constipation, anxiety, confusion, blurred vision, catatnia, hallucination, psychosis, paranoia
  5. ECG = sinus tachycardia, wide QRS QT prolongation ๋„ ๊ฐ€๋Šฅ
  6. toxicity dose >450mg ์ดˆ๊ณผ ์‹œ์—(๋ฏธ๋งŒ์ธ ๊ฒฝ์šฐ์—๋Š” ๋…์„ฑ ๊ฑฐ์˜ ์—†์Œ)
  7. 24์‹œ๊ฐ„ ์ด์ƒ์€ ์ง€์ผœ๋ด์•ผ ํ•จ, 24์‹œ๊ฐ„ ์ง€๋‚˜๊ณ ์„œ๋„ seizure ๊ฐ€๋Šฅํ•ด์„œ
  8. Tx = seizure ์‹ฌํ•˜๋ฉด ativan 2mg ์ •๋„ ์ฃผ๊ธฐ, ecg monitor, 1์‹œ๊ฐ„ ๋‚ด๋ฉด charcoal

  9. Mirtazapine

  10. a-adrenergic receptors, serotonin receptor block โ†’ NE, serotonin ์ฆ๊ฐ€ ํšจ๊ณผ
  11. 2์‹œ๊ฐ„ ๋‚ด ํก์ˆ˜๋จ
  12. ๋ถ€์ž‘์šฉ = sedation, confusion, coma, respiratory depression
  13. ECG = sinus tachycardia, QT prolongation ๋„ ๊ฐ€๋Šฅ
  14. ์ฆ์ƒ ์—†์œผ๋ฉด 6์‹œ๊ฐ„ ์ง€์ผœ๋ณธ ํ›„ ํ‡ด์› ๊ฐ€๋Šฅ
  15. Tx = supportive care, 1์‹œ๊ฐ„ ๋‚ด๋ฉด charcoal

  16. Nefazodone

  17. relatively benign
  18. 2์‹œ๊ฐ„ ๋‚ด ํก์ˆ˜๋จ
  19. ๋ถ€์ž‘์šฉ = drowsiness, hypotension,
  20. ECG = mild bradycardia, QT prolongation
  21. Tx = supprotive care

  22. Trazodone

  23. serotonin reuptake inhibitor, serotonin receptor antagonist, a- adrenergic receptor ์— ๊ฐ•ํ•œ affinity
  24. 1-2์‹œ๊ฐ„ ๋‚ด ํก์ˆ˜ ์‹œ์ž‘, 6์‹œ๊ฐ„ ๋‚ด ์ตœ๋Œ€์น˜๋กœ ํก์ˆ˜๋จ
  25. ๋ถ€์ž‘์šฉ = orthostatic hypotension, sedation, priapism(๋ฐœ๊ธฐ์ง€์†์ฆ), CNS depression, ataxia, dizziness, coma, seizure
  26. ECG = QT prolongation, polymorphic ventricular tachycardia(torsades de pointes)
  27. toxicity dose >2grams or co-ingestion of other substances
  28. 6-12์‹œ๊ฐ„ ๋‚ด neurologic sx ํ˜ธ์ „, 24์‹œ๊ฐ„ ์ง€๋‚˜๋ฉด ํ•ด์†Œ๋จ
  29. ์ฆ์ƒ ์—†์œผ๋ฉด 4-6์‹œ๊ฐ„ ์˜ต์ € ํ›„ ํ‡ด์›, ์ฆ์ƒ ์žˆ์œผ๋ฉด ์ž…์›ํ•ด ๋ชจ๋‹ˆํ„ฐ ํ•„์š”
  30. Tx = IV fluid for hypotension โ†’ ์•ˆ๋˜๋ฉด norpin, ecg monitor, 1์‹œ๊ฐ„ ๋‚ด๋ฉด charcoal, ECG ์ด์ƒ์€ IV magnesium sulfate

  31. Vilazodone

  32. serotonin reuptake inhibitor
  33. 2-24์‹œ๊ฐ„ ๋™์•ˆ ์ฆ์ƒ ๊ฐ€๋Šฅ, ๋ช‡๋ช‡์€ 24์‹œ๊ฐ„ ์ด์ƒ ์ฆ์ƒ ๋ณด์ผ์ˆ˜๋„
  34. ๋ถ€์ž‘์šฉ = drowsiness, vomiting, agitation, serotonin SD ๊ฐ€๋Šฅ
  35. ECG = sinus tachycardia

  36. Vortioxetine

  37. serotonin reuptake inhibitor
  38. ๋ถ€์ž‘์šฉ = nausea, vomiting, constipation, serotonin SD ๊ฐ€๋Šฅ

*Selective serotonin reuptake inhibitors(SSRI) = escitalopram, fluxetine a. only serotonin reuptake inhibition b. escitalopram, citalopram ์€ peak plasma level 2-4์‹œ๊ฐ„ / ๊ทธ ์™ธ 4-8์‹œ๊ฐ„ ํ›„ c. fluoxetine ์€ ๋ฐ˜๊ฐ๊ธฐ๊ฐ€ 7-14์ผ์ด๋ผ, clinical effect ๊ฐ€ 5์ฃผ ์ง€์†๋  ์ˆ˜ ์žˆ์Œ d. ๋ถ€์ž‘์šฉ = nausea, vomiting, sedation, tremor, akinesia, dyskinesia, parkinsonian sx e. ECG = sinus tachycardia, QRS widening, QT prolongation f. 24์‹œ๊ฐ„ ์ง€๋‚˜๋ฉด ECG ์ •์ƒํ™” g. 10% ์ •๋„ serotonin SD ๋ฐœ์ƒ h. ์ฆ์ƒ ์—†์–ด๋„ 6์‹œ๊ฐ„์€ ์˜ต์ € ํ›„ ํ‡ด์›, ์ฆ์ƒ ์žˆ์œผ๋ฉด ์ž…์›ํ•ด cardiac monitor i. Tx = seizure ์‹œ์— BZD โ†’ phenobarbital, ECG monitor, 1์‹œ๊ฐ„ ๋‚ด๋ฉด charcoal

*Serotonin/NE reuptake inhibitor(SNRI) a. venlafaxine ์€ 2์‹œ๊ฐ„ ๋‚ด ํก์ˆ˜, duloxetine dms 6-10์‹œ๊ฐ„ ๋‚ด ํก์ˆ˜ b. NE reuptake inhibit ํ•˜์—ฌ ๊ต๊ฐ ์‹ ๊ฒฝ๊ณ„ ํ™œ์„ฑํ™” c. ๋ถ€์ž‘์šฉ = tachycardia, HTN, diaphoresis, tremor, mydriasis, altered consciousness, rhabdomyolysis, seizure d. ECG = sinus tachycardia, QRS widening, QT prolongation e. ์ฆ์ƒ ์—†์œผ๋ฉด 6์‹œ๊ฐ„ ์˜ต์ € ํ›„ ํ‡ด์›, ์„œ๋ฐฉ์ •์€ 24์‹œ๊ฐ„ ์˜ต์ €, ์ฆ์ƒ ์žˆ์œผ๋ฉด ๋ชจ๋‹ˆํ„ฐ e. Tx = seizure ์‹œ BZD, ECG monitor, 1์‹œ๊ฐ„ ๋‚ด๋ฉด charcoal

SS NMS
์›์ธ SSRI, MAOI, tramadol ๋“ฑ ์„ธ๋กœํ† ๋‹Œ ์ฆ๊ฐ€ antipsychotics, dopamine antagonist ๋กœ ๋„ํŒŒ๋ฏผ ์ฐจ๋‹จ
๋ฐœ์ƒ ์‹œ๊ฐ„ ๋งค์šฐ ๋น ๋ฆ„, 24์‹œ๊ฐ„ ๋‚ด ๋А๋ฆผ, ๋ฉฐ์น ~๋ช‡ ์ฃผ์— ๊ฑธ์ณ ์„œ์„œํžˆ(1-3์ผ)
๊ทผ์œก tremor, ๊ฐ„๋Œ€์„ฑ ๊ฒฝ๋ จ myoclonus, ์ฃผ๋กœ ํ•˜์ฒด์—์„œ hyperreflexia ๋ณด์ž„(๋ฐœ๋ชฉ ์ –ํžˆ๋ฉด ๋œ๋œ ๋–จ๋ฆฌ๋ฆฌ๋Š” ๊ฐ„๋Œ€์„ฑ ๊ฒฝ๋ จ ๋ณด์ž„) ๊ทผ๊ฐ•์ง lead pipe rigidity, bradyreflexia, bradykinesia
๋™๋ฐ˜ ์ฆ์ƒ ์žฅ์Œ ์ฆ๊ฐ€, ๋™๊ณต ํ™•๋Œ€, ์„ค์‚ฌ ๋“ฑ ํ•ญ์ง„ ์˜์‹ ์ €ํ•˜, ์‹ฌํ•œ ๋ฐœํ•œ, ์‚ผํ‚ด ๊ณค๋ž€
๊ฒ€์‚ฌ ์†Œ๊ฒฌ leukocytosis, CK-MB ๊ธ‰๊ฒฉ ์ƒ์Šน
์น˜๋ฃŒ **cyproheptadine(์„ธ๋กœํ† ๋‹Œ ๊ธธํ•ญ์ œ)
benzodiazepine(์ง„์ •์ œ)** **bromocriptine(dopamine agonist)
dantrolene(๊ทผ์ด์™„์ œ**, ๊ทผ์œก ca ๋ฐฉ์ถœ ์–ต์ œํ•ด ๊ทผ์œก ๊ฐ•์ง ์™„ํ™”)
benzodiazepine(์ง„์ •์ œ)

Chapter 179. Monoamine Oxidase inhibitors(MAOIs) - ํ•ญ์šฐ์šธ์ œ(์š”์ฆ˜์€ ์ด ๋ชฉ์ ์œผ๋กœ์˜ ์‚ฌ์šฉ์€ ๋œ ํ•จ), ํŒŒํ‚ค์Šจ๋ณ‘ ์น˜๋ฃŒ์ œ - one pill ๋งŒ์œผ๋กœ๋„ ์‹ ์ƒ์•„ ์‚ฌ๋ง ๊ฐ€๋Šฅํ•  ์ •๋„๋กœ life threatening - ๋ณต์šฉ ํ›„ 6์‹œ๊ฐ„-24์‹œ๊ฐ„ - ๋‹ค๋ฅธ ๋งŽ์€ ์•ฝ๊ณผ ์ƒํ˜ธ์ž‘์šฉํ•˜์—ฌ, MAOI DI ๋กœ ์˜จ ๊ฒฝ์šฐ ์ƒˆ๋กœ์šด ์•ฝ์ œ๋ฅผ ์ฃผ์ง€ ๋ง ๊ฒƒ, ๋‹ค๋ฅธ ์•ฝ ์‹œ์ž‘ํ• ์‹œ์—๋„ MAOI ์ค‘๋‹จ ํ›„ 2์ฃผ๋Š” ์ง€๋‚˜๊ณ ์„œ ์‹œ์ž‘ - 1-2mg/kg ์‹œ ๋…์„ฑ ๊ฐ€๋Šฅ, 2-3mg/kg ์ด์ƒ ์‹œ ์ƒ๋ช… ์œ„ํ˜‘, 4-6mg/kg ์ด๋ฉด ์น˜์‚ฌ๋Ÿ‰


Chapter 180. antipsychotics

massive overdose(30g์ด์ƒ ์„ญ์ทจ, 4hr serum AAP level >300ug/ml*์ธ ๊ฒฝ์šฐ) = glutathione์ด ๊ณ ๊ฐˆ๋˜๋ฉด์„œ ๋ฐœ์ƒํ•ด์„œ, Fomepizole(ethylene glycol, methanol antidote) hemodialysis**๊นŒ์ง€ ํ•„์š”ํ• ์ˆ˜๋„

*์ตœ๊ทผ์Œ์‹๋ฌผ ์„ญ์ทจ ์ €ํ•˜ ์‹œ์—๋Š” ์น˜์‚ฌ๋Ÿ‰ ์•„๋‹ˆ์–ด๋„ ๊ธ‰์„ฑ๊ฐ„๋…์„ฑ ์žˆ์„ ์ˆ˜ ์žˆ๋‹ค,,

*DI ecg